Clinical trial
Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell…
NCT00183989 · University of Southern California, Other · Terminated
Key facts
| NCT number | NCT00183989 |
|---|---|
| Title | Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma |
| Official title | A Pilot Phase II Trial of Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma |
| Lead sponsor | University of Southern California, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mantle Cell Lymphoma |
| Intervention type | Drug |
| Interventions | Fludarabine, Mitoxantrone and Rituximab |
| Enrollment | 30 |
| Start date | Aug 1, 2000 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: